Bisphosphonates

ID 150 Pill - yellow capsule-shape

Pill with imprint ID 150 is Yellow, Capsule-shape and has been identified as Ibandronate Sodium 150 mg. It is supplied by Alvogen Inc.

Ibandronate is used in the treatment of Prevention of Osteoporosis; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Ibandronate (oral/injection) (Ibandronate (oral/injection) [ eye-ban-dro-nate ])-ID 150-150 mg-Yellow-Capsule-shape
Ibandronate (oral/injection) (Ibandronate (oral/injection) [ eye-ban-dro-nate ])-ID 150-150 mg-Yellow-Capsule-shape

Ibandronate (oral/injection)
Generic Name: ibandronate (oral/injection) [ eye-ban-dro-nate ]
Imprint: ID 150
Strength: 150 mg
Color: Yellow
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Bisphosphonates
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 47781-0103
Inactive Ingredients: Lactose monohydrate, Crospovidone, Microcrystalline cellulose, Silicon dioxide, Sodium stearyl fumarate, Water, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs